BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34664096)

  • 1. Gd-EOB-DTPA-enhanced MRI-a noninvasive and short-term assessment method for liver necroinflammation after direct-acting antiviral (DAA) therapy in patients with chronic hepatitis C.
    Li A; Wu J; Cheng J; Feng C; Liu W; Li Y; Rao H; Huang R; Zhou G; Hong N; Wang Y
    Abdom Radiol (NY); 2022 Jan; 47(1):174-183. PubMed ID: 34664096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of high-stage liver fibrosis using ADC value on diffusion-weighted imaging and quantitative enhancement ratio at the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI at 1.5 T.
    Harada TL; Saito K; Araki Y; Matsubayashi J; Nagao T; Sugimoto K; Tokuuye K
    Acta Radiol; 2018 May; 59(5):509-516. PubMed ID: 28853292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the efficacy of Gd-EOB-DTPA-enhanced magnetic resonance imaging and magnetic resonance elastography in the detection and staging of hepatic fibrosis.
    Wu WP; Hoi CI; Chen RC; Lin CP; Chou CT
    Medicine (Baltimore); 2017 Oct; 96(42):e8339. PubMed ID: 29049250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining 99mTc-GSA single-photon emission-computed tomography and Gd-EOB-DTPA-enhanced magnetic resonance imaging for staging liver fibrosis.
    Tokorodani R; Kume T; Daisaki H; Hayashi N; Iwasa H; Yamagami T
    Medicine (Baltimore); 2023 Feb; 102(7):e32975. PubMed ID: 36800578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI.
    Donati OF; Hany TF; Reiner CS; von Schulthess GK; Marincek B; Seifert B; Weishaupt D
    J Nucl Med; 2010 May; 51(5):692-9. PubMed ID: 20395324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage.
    Juluru K; Talal AH; Yantiss RK; Spincemaille P; Weidman EK; Giambrone AE; Jalili S; Sourbron SP; Dyke JP
    J Magn Reson Imaging; 2017 Apr; 45(4):1177-1185. PubMed ID: 27527820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases?
    Tajima T; Akahane M; Takao H; Akai H; Kiryu S; Imamura H; Watanabe Y; Kokudo N; Ohtomo K
    Jpn J Radiol; 2012 Oct; 30(8):648-58. PubMed ID: 22836904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative evaluation of liver function with MRI Using Gd-EOB-DTPA.
    Ryeom HK; Kim SH; Kim JY; Kim HJ; Lee JM; Chang YM; Kim YS; Kang DS
    Korean J Radiol; 2004; 5(4):231-9. PubMed ID: 15637473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.
    Pan S; Wang XQ; Guo QY
    World J Gastroenterol; 2018 May; 24(18):2024-2035. PubMed ID: 29760545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.
    Li X; Li C; Wang R; Ren J; Yang J; Zhang Y
    PLoS One; 2015; 10(12):e0144247. PubMed ID: 26629904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Gd-EOB-DTPA-Enhanced MRI and Diffusion-Weighted Imaging in Detecting Residual Hepatocellular Carcinoma After Drug-Eluting Bead Transarterial Chemoembolization.
    Liu HF; Xu YS; Liu Z; Che KY; Sheng Y; Ding JL; Zhang JG; Lei JQ; Xing W
    Acad Radiol; 2021 Jun; 28(6):790-798. PubMed ID: 32414638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of Diffusion-Weighted Imaging and Hepatobiliary-Specific Contrast Agent Gd-EOB-DTPA in the Diagnosis and Differential Diagnosis of Focal Liver Lesions].
    Chen GY; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Sep; 53(5):737-743. PubMed ID: 36224672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.
    Hako R; Kristian P; Jarčuška P; Haková I; Hockicková I; Schréter I; Janičko M
    Can J Gastroenterol Hepatol; 2019; 2019():3024630. PubMed ID: 31058108
    [No Abstract]   [Full Text] [Related]  

  • 17. Coefficient of variation on Gd-EOB MR imaging: Correlation with the presence of early-stage hepatocellular carcinoma in patients with chronic hepatitis B.
    Lee JH; Kim YR; Lee GM; Ryu JH; Cho EY; Lee YH; Yoon KH
    Eur J Radiol; 2018 May; 102():95-101. PubMed ID: 29685552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing liver function in patients with HBV-related HCC: a comparison of T₁ mapping on Gd-EOB-DTPA-enhanced MR imaging with DWI.
    Ding Y; Rao SX; Chen C; Li R; Zeng MS
    Eur Radiol; 2015 May; 25(5):1392-8. PubMed ID: 25523455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time
    Haimerl M; Fuhrmann I; Poelsterl S; Fellner C; Nickel MD; Weigand K; Dahlke MH; Verloh N; Stroszczynski C; Wiggermann P
    Eur Radiol; 2018 Sep; 28(9):3591-3600. PubMed ID: 29532241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
    Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
    Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.